Dec 12 |
RedHill Biopharma regains compliance with Nasdaq listing rule
|
Dec 12 |
RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
|
Dec 4 |
RedHill secures funding for Phase 2 study of COVID-19 treatment
|
Dec 4 |
RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study
|
Nov 30 |
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
|
Nov 29 |
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Nov 29 |
Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
|
Nov 28 |
Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
|
Nov 27 |
Nasdaq Moves Higher; US New Home Sales Fall In October
|
Nov 27 |
RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant
|